BofA lowered the firm’s price target on Acumen (ABOS) to $8 from $9 and keeps a Buy rating on the shares, citing an updated cash position following the company’s Q3 update.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABOS: